Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air by Khan, M. Tanweer et al.
  
 University of Groningen
Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium
Faecalibacterium prausnitzii alive at ambient air
Khan, M. Tanweer; van Dijl, Jan Maarten; Harmsen, Hermie J M
Published in:
PLoS ONE
DOI:
10.1371/journal.pone.0096097
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2014
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Khan, M. T., van Dijl, J. M., & Harmsen, H. J. M. (2014). Antioxidants keep the potentially probiotic but
highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS ONE,
9(5), [e96097]. https://doi.org/10.1371/journal.pone.0096097
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Antioxidants Keep the Potentially Probiotic but Highly
Oxygen-Sensitive Human Gut Bacterium
Faecalibacterium prausnitzii Alive at Ambient Air
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Abstract
The beneficial human gut microbe Faecalibacterium prausnitzii is a ‘probiotic of the future’ since it produces high amounts
of butyrate and anti-inflammatory compounds. However, this bacterium is highly oxygen-senstive, making it notoriously
difficult to cultivate and preserve. This has so far precluded its clinical application in the treatment of patients with
inflammatory bowel diseases. The present studies were therefore aimed at developing a strategy to keep F. prausnitzii alive
at ambient air. Our previous research showed that F. prausnitzii can survive in moderately oxygenized environments like the
gut mucosa by transfer of electrons to oxygen. For this purpose, the bacterium exploits extracellular antioxidants, such as
riboflavin and cysteine, that are abundantly present in the gut. We therefore tested to what extent these antioxidants can
sustain the viability of F. prausnitzii at ambient air. The present results show that cysteine can facilitate the survival of F.
prausnitzii upon exposure to air, and that this effect is significantly enhanced the by addition of riboflavin and the
cryoprotectant inulin. The highly oxygen-sensitive gut bacterium F. prausnitzii can be kept alive at ambient air for 24 h
when formulated with the antioxidants cysteine and riboflavin plus the cryoprotectant inulin. Improved formulations were
obtained by addition of the bulking agents corn starch and wheat bran. Our present findings pave the way towards the
biomedical exploitation of F. prausnitzii in redox-based therapeutics for treatment of dysbiosis-related inflammatory
disorders of the human gut.
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Introduction
Diabetes, obesity, inflammatory bowel diseases and various
other metabolic disorders are intimately linked to changes in the
human gut microbiota [1–4]. It is thus important to develop
strategies and tools to revert the condition of ‘dysbiosis’, where the
human gut microbiota is substantially altered, to situations as
typically encountered in healthy individuals [1], [5–9]. Therefore,
the so-called ‘probiotic’ supplementation of gut microorganisms is
being considered as a highly promising novel therapeutic
approach for treating dysbiosis [7], [10], [11]. Such probiotics
are historically defined as ‘live microbial food supplements that
have beneficial effects on the host by improving its intestinal
microbial balance’ [12]. Importantly, the probiotics required for
treating dysbiosis do not only have to compete with pathogenic
bacteria and suppress them, but they should also help to positively
modulate the gut-microbial fermentation pathways [13]. This calls
for the development of novel probiotic formulations that include
microorganisms from the human gut microbiome, a formidable
resource of beneficial microbes.
Traditionally, the bacteria Lactobacillus acidophilus, Lactobacillus
casei, Bifidobacterium bifidum and Bifidobacterium longum, and the yeast
Saccharomyces boulardii have been employed as probiotics in humans.
These microorganisms are generally well-accepted and tolerated
amongst consumers [13]. Alternatively, the growth and/or activity
of particular gut microbes can be stimulated with non-digestible
food constituents, such as inulin-type fructans [14]. Such food
supplements are often referred to as ‘prebiotics’ [11], [15].
Generally, prebiotic supplementations are aimed to modulate
the composition of the gut microbiota in such a way that the
potentially health-promoting bacteria, such as lactobacilli and
bifidobacteria are stimulated [15], [16]. ‘Synbiotics’ are combina-
tions of probiotics and prebiotics that have a beneficial impact on
the host by improving the survival and establishment of beneficial
microbes in the gastrointestinal tract [11], [17]. Such synbiotics
may selectively stimulate microbial growth by activating the
metabolism of one, or a limited number of health-promoting
microbes. Importantly, the ingestion of probiotics, prebiotics or
synbiotics can modulate the short-chain fatty acid (SCFA) profiles
in the human colon [11]. Here, the most abundant SCFAs are
acetate, propionate and butyrate, which are generally detectable in
human feces at ratios of 60:20:20, respectively [18], [19]. The
butyrate level is of particular importance, because this SCFA
represents the most preferred energy source for colonocytes
[19],[20], stimulates cell proliferation [21], and promotes mucus
secretion from colonic mucosa [22]. In view of these benefits of
butyrate, butyrogenic bacteria are highly promising future
probiotics.
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One of the most important butyrate-producing bacteria in the
human colon is Faecalibacterium prausnitzii. This bacterium and its
close relatives, which are amongst the most abundant gut bacteria,
belong to the clostridial cluster IV [23]. Notably, faecalibacteria
are present at low numbers in patients with inflammatory-bowel
disease while, on the other hand, they display significant anti-
inflammatory effects in mouse colitis models [24]. These
observations imply that faecalibacteria contribute substantially to
gut health, which makes them prime candidates for inclusion in
probiotic or synbiotic formulations [25]. However, in contrast to
the fairly oxygen-tolerant probiotics that are commercialized
today, these probiotics of the future are highly oxygen-sensitive. In
fact, faecalibacteria cannot even withstand a few minutes of
exposure to ambient air [26]. This extreme oxygen-sensitivity is a
huge challenge for the development of probiotic or synbiotic
formulations that include F. prausnitzii or its close relatives.
Freeze-drying or lyophilization is commonly used to preserve
microorganisms since lyophylates can be stored for decades [27].
Accordingly, many microbes are stored as lyophilates in important
strain collections like the American Type Culture Collection
(ATCC) and the National Collection of Type Cultures (NCTC).
To overcome the potential viability loss during formulation, it is
Figure 1. Schematic representation of the methodology employed to investigate the survival of F. prausnitzii in different
formulations upon exposure to air. Steps 1–4 were conducted in an anaerobic chamber, and steps 5–7 were conducted aerobically in ambient
air. The final step 8, involving rehydration and viability assays, was conducted in an anaerobic chamber.
doi:10.1371/journal.pone.0096097.g001
Figure 2. Physical appearance of freeze-dried granules containing F. praunitzii. A, Formulation with cysteine and riboflavin results in
compact and pellet-like granules. B, Formulation with inulin, riboflavin and cysteine results in a foam-like matrix with a high bulk volume. C,
Formulation with wheat bran, inulin, corn starch, cysteine and riboflavin results in hard and compact granules with considerable bulk volume.
doi:10.1371/journal.pone.0096097.g002
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generally recommended to lyophilize concentrated cultures
containing .107 cells [27–29]. This ensures the presence of
sufficient viable cells after lyophilization, long-term storage and
reconstitution [27], [29]. For strain preservation purposes, the
survival of ,0.1% of the original cell population is in principle
sufficient [29]. In contrast, for probiotic fomulation it is important
that as many bacteria as possible survive lyophilization and
subsequent storage. Therefore, glycerol, mannitol, sorbitol, inulin,
dextrin and Crystalean have been frequently applied as cryopre-
servants to protect probiotic formulations during lyophilization
and to enhance their shelf-life [30], [31]. However, the selection of
appropriate and compatible cryopreservants remains a major
challenge and no suitable protectants were so far reported for
faecalibacteria.
Inulin-type fructans are generally well-known prebiotics, which
have been shown to increase the number of bifidobacteria both in
vitro and in vivo [14], [32]. In addition, inulin has been widely
employed as a cryopreservative in lyophilization procedures [27],
[30], [31], [33]. Similarly, starch and wheat bran can serve as
prebiotics [34] that possibly enhance the efficacy of synbiotic
formulations [35], [36]. Antioxidants such as glutathione, ascor-
bate and cysteine can further enhance the viability of probiotics
during storage [37]. Recently, we have shown that F. prausnitzii can
exploit flavins and oxidized thiols as redox mediators to shuttle
electrons to oxygen [38]. In this way, F. prausnitzii can survive and
thrive under moderately oxygenized conditions as encountered in
the human gut, where oxygen diffuses in from the epithelial cell
layers. In the present study, we therefore investigated whether and
how riboflavin and cysteine can be used to develop formulations
that preserve viable F. prausnitzii cells under oxygenized conditions.
Our findings show that this is indeed a feasible strategy, which
paves the way for the development of synbiotics containing
faecalibacteria.
Materials and Methods
Bacterial strains and culturing conditions
F. prausnitzii strain A2-165 (DSM 17677), previously described
[26] was maintained at 37uC on yeast extract, casitone, fatty acid
and glucose medium (YCFAG) in an anaerobic chamber. To
maintain anaerobic conditions a gas mixture of N2 (81%), H2
(11%) and CO2 (8%) was used. For formulation experiments, the
Figure 3. Scanning electron micrographs of F. prausnitzii-containing formulations. All formulations shown contained cysteine and
riboflavin supplemented either with corn starch (A), inulin (B), or wheat bran, corn starch and inulin (C and D). Corn starch has a discrete bead-like
appearence (A). In contrast, inulin forms a flake-like matrix (B), that can form a coating around corn starch and/or wheat bran, thereby entrapping the
bacterial cells (C and D). Images A, B and C were recorded at 5006magnification, and image D was recorded at 15006magnification. The arrows
indicate entrapped F. prausnitzii cells.
doi:10.1371/journal.pone.0096097.g003
Figure 4. Tentative schematic representation of a formulation
in which F. prausnitzii cells were adhered on cornstarch or
wheat bran, and entrapped by an inulin matrix containing
riboflavin and cysteine as antioxidants and redox mediators.
doi:10.1371/journal.pone.0096097.g004
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bacterial cells were grown in 50 ml of YCFAG broth to an optical
density at 600 nm of ,1. The average yield of bacterial cells on a
wet-weight basis was around 0.1 g per 50 ml of broth. Cells were
harvested by centrifugation (3300 g) for 10 min. The resulting
pellet was then washed in PBS and re-centrifuged to obtain a cell
pellet that was used for further experiments.
Formulation procedure
Bacterial cell pellets from 50 ml cultures were re-suspended in
400 ml of inulin solution (10%) with or without 0.2% cysteine or
phosphate-buffered saline (PBS). To these mixtures was added
either 200 ml of a 16.5 mM riboflavin solution in PBS, or 200 ml
PBS without further additions. In some experiments, the bacterial
slurry was later mixed with 0.5 g of wheat bran, with or without
1 g of corn starch. The mixtures were then homogenized with a
sterile spatula and frozen at 220uC. Upon freezing, the mixtures
were lyophilized for 3 h and stored at 220uC until further
analysis. Notably, the culturing of bacteria, harvesting, granula-
tion, and freezing were conducted anaerobically, while freeze-
drying and storage were performed aerobically.
Stability and viability testing
For stability analyses, freeze-dried granules were exposed to
atmospheric air at ambient temperatures for 0 h, 6 h, 11 h or
24 h. Next, the granules were placed in an anaerobic chamber,
and rehydrated in PBS to yield 1:10 dilutions. After rehydration,
100 ml or 200 ml of the diluent was plated on YCFAG agar and
incubated anaerobically at 37uC for 24 to 36 h. Colony forming
units (CFU) per ml were estimated by counting individual colonies
formed on the agar plates. The relative stability of lyophilized
mixtures was calculated by dividing the CFU/ml determined after
exposure to ambient air for a particular period of time by the
CFU/ml of the rehydrated mixture immediately after formulation
(T0). All experiments have been repeated at least twice on different
dates.
Scanning electron microscopy
Lyophilized granules of different composition were mounted on
aluminum stubs, sputtered with gold particles and examined with
a JEOL 6301F scanning Electron Microscope (EM), as previously
described [39].
Results and Discussion
To investigate whether it is possible to formulate F. prausnitzii
cells in such a way that they can withstand ambient air for several
hours, a formulation protocol was established as schematically
depicted in Figure 1. The initial formulation steps including
bacterial cultivation, harvesting and mixing with particular
compounds were carried out under anaerobic conditions. After
lyophilization, the resulting granules were frozen (220uC) and
stored aerobically at 220uC until further use. Depending on their
composition, the lyophilized mixtures were recovered as granules
with different morphologies. For example, Figure 2A shows the
compact flake-like appearance of a lyophilized preparation
containing cysteine, riboflavin and F. prausnitzii cells; Figure 2B
shows the granules that were obtained when inulin was present in
addition to cysteine, riboflavin and F. prausnitzii cells; and
Figure 2C shows the hard and compact granules that were
obtained when F. prausnitzii was formulated with corn starch,
wheat bran, inulin, cysteine and riboflavin. In the latter type of
formulation, the bacterial cells were found to adhere to the wheat
bran and/or cornstarch. Table 1 shows the relative viability of F.
prausnitzii in the different tested formulations upon exposure to
ambient air for 6, 11 or 24 h as compared to the bacterial counts
obtained immediately after the formulation (T0). Notably, the
established cryopreservant inulin did not detectably enhance
faecalibacterial survival by itself. The same was true for riboflavin,
despite its known antioxidant activity. On the other hand, cysteine
had a mildly protective effect, leading to about 10% bacterial
survival upon 24 h exposure to air. When combined, inulin and
riboflavin gave no detectable protection, but inulin and cysteine
were highly effective leading to almost 60% bacterial survival.
Intriguingly, the same level of protection was achieved with a
combination of riboflavin and cysteine. The highest level of
protection of around 70% was achieved when cysteine was
combined with riboflavin and inulin (Table 1). It should be noted
that the foamy material that was obtained when the faecalibacteria
were formulated with cysteine, riboflavin and inulin is difficult to
handle (Fig. 2B). Therefore, we tested the possibility to use corn
starch and wheat bran as bulking agents. Notably, these two
compounds had no protective effects on the faecalibacteria,
neither by themselves nor in combination with inulin (Table 1
and data not shown). However, close to maximum faecalibacterial
survival (,60%) was observed when corn starch and wheat bran
were combined with inulin, riboflavin and cysteine. This finding is
important, because the respective mixture yields hard and
compact granules with a considerable bulk volume (Fig. 2C).
Importantly, also in the mixture containing inulin, riboflavin,
cysteine, corn starch and wheat bran, the inclusion of cysteine is
crucial for bacterial protection against air (Table 1). Somewhat
unexpectedly, when corn starch was present, also inulin and wheat
bran did contribute to the faecalibacterial survival, but a mix of
only these two compounds did not support faecalibacterial survival
at ambient air (Table 1). Altogether, we conclude that a
formulation of F. prausnitzii with inulin, riboflavin, cysteine, corn
starch and wheat bran is optimal both in terms of faecalibacterial
survival and the type of granules that are obtained.
As shown by scanning EM, corn starch forms discrete bead like
structures during our formulation procedure (Fig. 3A) while inulin
forms a flake-like matrix (Fig. 3B). When combined, corn starch,
wheat bran and inulin form a matrix upon lyophilization that
seems to facilitate faecalibacterial entrapment on corn starch and
wheat bran particles as shown in Figure 3 (C and D) and
schematically represented in Figure 4.Keeping highly oxygen-
sensitive bacteria, such as F. prausnitzii, alive in probiotic or
synbiotic formulations has been considered a major challenge [27].
In this study, we describe a methodology for formulating F.
prausnitzii, which allows cells of this bacterium to survive the
exposure to ambient air for at least 24 h. The principal concept
underlying our novel formulation is that the faecalibacterial cells
are coated with antioxidants, which protects them from the lethal
effects of oxygen when exposed to ambient air (Fig. 4). Bulking
agents, such as wheat bran and corn starch provide a substratum
for microbial cell adherence and inulin serves as a matrix to
capture the faecalibacterial cells on the corn starch and wheat
bran particles (Fig. 3D). Furthermore, the inulin can form an outer
matrix that incorporates the antioxidants cysteine and riboflavin
(Fig. 3, C and D). Notably, these compounds will not only protect
the faecalibacteria from oxidative damage, but they will also
facilitate faecalibacterial growth upon rehydration. The latter
relates to the fact that F. prausnitzii can use riboflavin and oxidized
cysteine to shuttle electrons to oxygen, which allows them to grow
to higher cell densities in moderately oxygenized environments
[38]. Inulin is well known for its cryopreservative properties [27],
[30], [33] and our data suggest that it protects the faecalibacteria
during lyophylization. However, inulin is not protective by itself
and it can only sustain the viability of faecalibacteria in
How to Keep F. prausnitzii Alive at Ambient Air
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combination with cysteine or, even better, cysteine plus riboflavin.
Furthermore, the addition of inulin also increases the bulk volume
of the formulation (Fig. 2B). While the different bulking agents
used in the present study result in variable granule sizes as shown
in Figure 2, we do not believe that this will result in major
differences in the surface areas exposed to oxygen since the
different granules are porous and exposed to oxygen on a
microscale regardless their macro size (Fig. 3). Instead, our present
findings imply that the oxygen protection is provided mainly
through the coating with antioxidants and inulin, which creates a
reducing environment in which F. prausnitzii can survive. At this
stage we do not exactly know why the survival of F. prausnitzii in
the presence of bulking agents is somewhat lower than when these
bulking agents are absent, but it could be due to the fact that the
bulking agents wheat bran and corn starch quickly attract moisture
that could lead to decreased survival upon exposure to ambient
air.Notably, the bulking agents corn starch, wheat bran and inulin
used in this study do not only facilitate the formulation procedure,
but they are also known to confer prebiotic effects when ingested
by the host [14], [34], [36]. For instance, prebiotic administration
of inulin is known to result in increased numbers of F. prausnitzii
and other beneficial gut microbes [14]. Wheat bran is a rich source
of arabinoxylan, which has been suggested to lower low-grade
chronic or systemic inflammation in obese mouse models [34]. In
addition, food supplementation with arabinoxylan is known to
counteract the dysbiosis induced by high fat diets [35]. Corn starch
or resistant starch can also modulate the gut microbiota, leading to
altered SCFA production profiles [40–43]. Lastly, cysteine is
known to counteract oxidative stress at the gut mucosal lining [44],
while F. prausnitzii is believed to have significant anti-inflammatory
effects [24], [45].
Altogether, the beneficial properties of the butyrogenic bacte-
rium F. prausnitzii and the compounds used for its formulation
indicate that our present approach has a strong potential to deliver
a novel and highly potent synbiotic. This synbiotic formulation
could be beneficial for the treatment of the patients with colitis, a
disease characterized by severe inflammation of the colon as well
as low counts of F. prausnitzii. Here, it would be clearly beneficial to
avail of an effective synbiotic formulation to restore high counts of
F. prausnitzii. Our present findings represent a major step forward
towards the development of such a synbiotic, as we now know how
to keep the highly oxygen-sensitive bacterium F. prausnitzii and
possibly other anaerobic gut microbes alive at ambient air.
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